Gastric Peroral Endoscopic Myotomy in a Patient with Long-Standing Gastroparesis.

Abstract: Gastroparesis is a chronic motility disorder characterized by slow gastric emptying. It causes unpleasant symptoms that results in poor quality of life. Current treatments include symptomatic management with antiemetics and prokinetic medications, surgical treatment through pyloric myotomy, surgical pyloroplasty, gastric pacemaker, and endoscopic treatments like pyloric injection of botulinum toxin, transpyloric stents, and gastric peroral endoscopic myotomy (G-POEM). Metoclopramide is the only medicine approved by U.S. Food and Drug administration for gastroparesis and it can cause serious side effects. G-POEM is an advanced, minimally invasive endoscopic intervention for the treatment of gastroparesis. This procedure has demonstrated noteworthy improvements in symptoms and is now considered the preferred approach for permanent treatment of gastroparesis. This article discusses the case of gastroparesis in a 67-year-old female who was treated by G-POEM, which subsequently resulted in a significant reduction in her gastroparesis cardinal symptom index (GCSI) score and resolution of most of her symptoms. Keywords: gastric peroral endoscopic myotomy (G-POEM), gastroparesis cardinal symptom index (GCSI)

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-10-13
DOI
https://doi.org/10.5281/zenodo.17337686
Primary Topic
Gastrointestinal motility and disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Gastric Peroral Endoscopic Myotomy in a Patient with Long-Standing Gastroparesis.

Zenodo (CERN European Organization for Nuclear Research)
Gastrointestinal motility and disorders
article

Gastric Peroral Endoscopic Myotomy in a Patient with Long-Standing Gastroparesis.

article en

Abstract

Abstract: Gastroparesis is a chronic motility disorder characterized by slow gastric emptying. It causes unpleasant symptoms that results in poor quality of life. Current treatments include symptomatic management with antiemetics and prokinetic medications, surgical treatment through pyloric myotomy, surgical pyloroplasty, gastric pacemaker, and endoscopic treatments like pyloric injection of botulinum toxin, transpyloric stents, and gastric peroral endoscopic myotomy (G-POEM). Metoclopramide is the only medicine approved by U.S. Food and Drug administration for gastroparesis and it can cause serious side effects. G-POEM is an advanced, minimally invasive endoscopic intervention for the treatment of gastroparesis. This procedure has demonstrated noteworthy improvements in symptoms and is now considered the preferred approach for permanent treatment of gastroparesis. This article discusses the case of gastroparesis in a 67-year-old female who was treated by G-POEM, which subsequently resulted in a significant reduction in her gastroparesis cardinal symptom index (GCSI) score and resolution of most of her symptoms. Keywords: gastric peroral endoscopic myotomy (G-POEM), gastroparesis cardinal symptom index (GCSI)

Zenodo (CERN European Organization for Nuclear Research)
No poverty
Openalex Percentile: Top 36%
Gastrointestinal motility and disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Gastric Peroral Endoscopic Myotomy in a Patient with Long-Standing Gastroparesis. · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS